NIH Offers Ebola Vaccine Invention to Private Firms
Published Date: 7/24/2026
Notice
Summary
The National Institutes of Health is offering a new Ebola vaccine invention for companies to license and develop quickly. This vaccine targets the Bundibugyo virus and promises fast and lasting protection, helping stop outbreaks in Central Africa. Businesses interested in licensing should act soon to bring this life-saving tech to market and can contact NIH for details.
Analyzed Economic Effects
5 provisions identified: 4 benefits, 1 costs, 0 mixed.
NIH Offers Ebola Vaccine For Licensing
The NIH is offering a new rVSV-BDBV Ebola vaccine invention (HHS Ref. No. E-122-2026-0) for companies to license to commercialize. Businesses can contact Terrence Joyce (301-761-7235) or the NIAID Technology Transfer Office to request licensing information and start development.
Collaborative Research Opportunities Available
NIAID is seeking statements of capability or interest for collaborative research to further develop, evaluate, or commercialize the rVSV-BDBV vaccine. Interested parties should contact Terrence Joyce at 301-761-7235 or the NIAID Technology Transfer Office and may enter collaboration agreements.
Pre-Clinical Vaccine Shows Rapid Protection
The vaccine is at the pre-clinical stage and a single intramuscular dose protected nonhuman primates from disease within 3 days of vaccination. The licensable materials include the recombinant rVSV-BDBV vaccine and the DNA plasmid pATX-VSV[Delta]G-BDBV GP to support development and manufacturing.
Foreign Patent Coverage May Be Available
The notice states that foreign patent applications are filed on selected inventions to extend market coverage and those foreign filings may also be available for licensing. This can affect market rights and geographic scope for licensees.
Confidential Disclosure Agreement Required
A signed Confidential Disclosure Agreement (CDA) is required to receive copies of unpublished information related to the invention from NIAID. Companies must sign a CDA before obtaining technical details for licensing or collaboration.
Personalized for You
How does this regulation affect your finances?
Personalize government policy and PRIA will tell you what this federal register document means for your household, plus every other regulation we track. PRIA reads each provision against your financial profile to show you exactly what matters to your wallet.
Key Dates
Department and Agencies
Related Federal Register Documents
2026-20771, Center for Scientific Review; Notice of Closed Meetings
The Center for Scientific Review at the NIH is holding several closed virtual meetings in early November 2026 to review and evaluate grant applications. These meetings protect private info and trade secrets, affecting researchers seeking funding. No direct money changes are announced, but these reviews decide who gets research grants.
2026-20705, Prospective Grant of Exclusive License, Inter-Institutional Agreement-Institution Lead: Antibody Specifically Binding to Severe Fever With Thrombocytopenia Syndrome Virus Antigen and Use Thereof
The National Institute of Allergy and Infectious Diseases plans to give Korea National Institute of Health an exclusive license to develop and sell a special antibody that targets a dangerous virus causing severe fever and low platelets. This deal helps speed up turning the invention into real-world treatments. Comments or license requests must be sent by October 26, 2026.
2026-20424, National Cancer Institute; Notice of Meeting
The President's Cancer Panel is holding a free virtual meeting on October 15, 2026, to talk about how GLP-1 medications can help lower cancer risks linked to obesity. Anyone interested can join online or send in comments beforehand. This meeting is a great chance for patients, doctors, and researchers to learn about new ways to fight cancer and improve health.
2026-20365, Center For Scientific Review; Notice of Closed Meetings
The NIH's Center for Scientific Review is holding several closed virtual meetings on October 29-30, 2026, to review and evaluate grant applications. These meetings protect private info and trade secrets while deciding which research projects get funding. Scientists applying for grants in areas like biochemistry, software engineering, and mental health will be affected, with no direct money changes announced but important decisions coming soon.
2026-20151, Notice of NIH Tribal Consultations and Listening Session
The NIH is inviting Tribal leaders and members to join two important meetings and a listening session during the National Congress of American Indians Annual Convention in October 2026. They’ll talk about new health research projects, renewing support for Tribal health centers, and shaping a new Tribal Data Sovereignty Policy. Tribes can also send their thoughts by November 20, 2026, helping shape future health programs and policies.
2026-19719, Center for Scientific Review; Amended Notice of Meeting
The NIH’s Center for Scientific Review is shortening a key meeting from two days to just one day on October 13, 2026, keeping the same 9 a.m. to 6 p.m. hours. This change affects members of the Surgical Sciences and Bioengineering review group and means less time in the room but no public access. No money changes or delays are expected—just a quicker, tighter meeting!
Previous / Next Documents
Previous: 2026-14965, Agency Information Collection Activities; Extension, Without Change, of a Currently Approved Collection: Request for Fee Waiver
The Department of Homeland Security is keeping its current form for asking to waive immigration fees, with no changes. They’re asking the public to share thoughts by August 24, 2026, but this won’t cost anyone extra or change how the form works. This is just a routine step to keep the fee waiver request available and easy to use.
Next: 2026-14967, Foreign-Trade Zone (FTZ) 45; Authorization of Limited Production Activity; SSI Shredding Systems, Inc.; (Industrial Shredders and Compactors); Wilsonville and Portland, Oregon
SSI Shredding Systems in Oregon got the green light to start limited production of industrial shredders and compactors in their Foreign-Trade Zone facilities. They must pay duties on steel and aluminum parts unless special trade rules apply. This change kicks in now and helps SSI grow while following trade rules.